TBED Works: NCBiotech supports early-stage startups that ultimately shine
Most startups begin rich in vision but poor in financial support. Some founders have been known to go to great lengths to advance what they know to be worthwhile project. Asklepios BioPharmaceutical (AskBio), established in 2001, survived its earliest days with the help of bake sales held by families whose children had muscular dystrophy and believed in the startup's potential to develop treatments for the condition. When Lindy Biosciences was founded in 2017, its founder was not financially compensated for her time. However, after early assistance from the North Carolina Biotechnology Center (NCBiotech), both companies now have market values measured in billions of dollars.